Skip to Content

User Reviews for Ciprofloxacin

Also known as: Ciloxan

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Learn more about Ciprofloxacin.

Condition	Reviews	Compare	Avg. Ratings

Reviews for Ciprofloxacin

No reviews have yet been submitted. Be the first to review this drug.

Learn more about

More about ciprofloxacin ophthalmic

Consumer resources

Other brands: Ciloxan

Professional resources

Related treatment guides

Antibiotics 101

Everything you need to know about antibiotics:

Drug Status

Availability Rx Prescription only

Pregnancy Category C Risk cannot be ruled out

CSA Schedule N Not a controlled drug

Approval History Calendar Drug history at FDA

Dry Eye

FDA Consumer Updates

More FDA updates

Drug Class

Ophthalmic anti-infectives

Recently Approved

Amjevita Amjevita (adalimumab-atto) is an anti-TNF-α monoclonal antibody biosimilar to Humira, approved for ...
Exondys 51 Exondys 51 (eteplirsen) is an antisense oligonucleotide indicated for the treatment of Duchenne...
Kyleena Kyleena (levonorgestrel-releasing intrauterine system) is a low-dose progestin-containing...
Yosprala Yosprala (aspirin and omeprazole) is a platelet aggregation inhibitor and proton pump inhibitor...

Related News and Articles

Health Tip: Remember Eye Protection at Work September 27, 2016
Improper Use of Contact Lenses Can Trigger Serious Eye Damage, CDC Says August 18, 2016
FDA Bolsters Warnings About Class of Antibiotics July 26, 2016

Help and Support

Looking for answers? Ask a question

Drugs.com Discount Card

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Sep 2nd, 2016), Cerner Multum™ (updated Sep 5th, 2016), Wolters Kluwer™ (updated Aug 8th, 2016) and others. To view content sources and attributions, please refer to our editorial policy.